Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study

doi:10.4254/wjh.v8.i17.731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9858)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

405

WORD

292

HTML

4787

Figures (1-4)

292

Sum=5776

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

417

Download

1010

Sum=1427

Publishing Process of This Article

Item

Count

Browse

892

Download

1763

Sum=2655

Jun 18, 2016 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Hepatol. Jun 18, 2016; 8(17): 731-738
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.731

Full Size Figure Download Figure

Figure 2 Ultrasonography-guided fiducial placement. The two different gold markers are sonographically undistinguishable. A: Needle delivering fiducial into a liver mass; B: Hyperechoic flexible wire notched gold marker, 0.28 mm × 10 mm, Gold Anchor marker (arrow) near a liver mass; C: Hyperechoic Grain cylindrical gold marker, 1 mm × 4 mm (arrow) near a liver mass.

Citation: Marsico M, Gabbani T, Livi L, Biagini MR, Galli A. Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study. World J Hepatol 2016; 8(17): 731-738
URL: https://www.wjgnet.com/1948-5182/full/v8/i17/731.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i17.731